Mark D Minden (Mark Minden)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 30

Top Topics

Acute Myeloid Leukemia

Intensive Care Unit

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Science translational medicine

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Agustina Perusini, Daniela Zackova, TaeHyung Kim, Katia B B Pagnano, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomas Jurcek, Jaeyoon John Kim, Young Seok Yoo, Seongyoon Yi, Hyewon Lee, Kyoung Ha Kim, Myunghee Chang, Jose-Mario Capo-Chichi, Jessie J F Medeiros, Andrea Arruda, Mark D Minden, Zhaolei Zhang, Sagi Abelson, Jiri Mayer, Dennis Dong Hwan Kim
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes. Blood advances (2024)
Qianghua Zhou, Davidson Zhao, Morjgan Zarif, Marta B Davidson, Mark D Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
Real-World Analysis of Clinical Outcomes in AML, Myelodysplasia-Related: a Comparison of ICC and WHO-HAEM5 Criteria. Blood advances (2024)
Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D Minden, Aaron D Schimmer, Andre C Schuh, Hassan Sibai, Karen W L Yee, Anne Tierens, Auro Viswabandya, Vikas K Gupta
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood advances 8 (5) (2024)
Enoch Tin, JongBok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances (2024)
Maria Agustina Perusini, Daniela Zackova, Taehyung Kim, Katia B B Pagnano, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Jaeyoon Kim, Youngseok Yoo, Seongyoon Yi, Hyewon Lee, Kyoung Ha Kim, Myunghee Chang, Jose-Mario Capo-Chichi, Jessie J F Medeiros, Andrea Arruda, Mark D Minden, Zhaolei Zhang, Sagi Abelson, Jiri Mayer, Dennis Dong Hwan Kim
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes. Blood advances 8 (10) (2024)
Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Marta B Davidson, Mark D Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria. Blood advances 8 (7) (2024)
Maria Agustina Perusini, Daniela Zackova, Taehyung Kim, Katia B B Pagnano, Carolina Pavlovsky, Ivana Ježíšková, Anežka Kvetková, Tomáš Jurček, Jaeyoon Kim, Youngseok Yoo, Seongyoon Yi, Hyewon Lee, Kyoung Ha Kim, Myunghee Chang, Jose-Mario Capo-Chichi, Jessie J F Medeiros, Andrea Arruda, Mark D Minden, Zhaolei Zhang, Sagi Abelson, Jiri Mayer, Dennis Dong Hwan Kim
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes. Blood advances 8 (10) (2024)
Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven Chan, Dawn Maze, Mark D Minden, Aaron D Schimmer, Andre C Schuh, Hassan Sibai, Karen W L Yee, Anne Tierens, Auro Viswabandya, Vikas K Gupta
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood advances 8 (5) (2024)
Marta B Davidson, James A Kennedy, Jose-Mario Capo-Chichi, Yuliang Shi, Wei Xu, Verna Cheung, Andrea Arruda, Aniket Bankar, Guillaume Richard-Carpentier, Steven M Chan, Dawn Maze, Mark D Minden, Aaron D Schimmer, Andre C Schuh, Hassan Sibai, Karen W L Yee, Anne Tierens, Auro Viswabandya, Vikas K Gupta
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood advances (2024)
Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances 8 (12) (2024)
Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances 8 (12) (2024)
Enoch Tin, Jong Bok Lee, Ismat Khatri, Yoosu Na, Mark D Minden, Li Zhang
Double-negative T cells utilize a TNFα-JAK1-ICAM-1 cytotoxic axis against acute myeloid leukemia. Blood advances 8 (12) (2024)
Qianghua Zhou, Davidson Zhao, Mojgan Zarif, Marta B Davidson, Mark D Minden, Anne Tierens, Yu Wing Tony Yeung, Cuihong Wei, Hong Chang
A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria. Blood advances 8 (7) (2024)
Ana Vujovic, Laura P M H de Rooij, Ava Keyvani Chahi, He Tian Tony Chen, Brian A Yee, Sampath Kumar Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E Dick, Mark D Minden, Daniel Schramek, Gene W Yeo, Kristin J Hope
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood cancer discovery (2023)
Ana Vujovic, Laura P M H de Rooij, Ava Keyvani Chahi, He Tian Tony Chen, Brian A Yee, Sampath Kumar Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E Dick, Mark D Minden, Daniel Schramek, Gene W Yeo, Kristin J Hope
In vivo screening unveils pervasive RNA-binding protein dependencies in leukemic stem cells and identifies ELAVL1 as a therapeutic target. Blood cancer discovery (2023)
Alex C H Liu, Severine Cathelin, Yitong Yang, David L Dai, Dhanoop Manikoth Ayyathan, Mohsen Hosseini, Mark D Minden, Anne Tierens, Steven M Chan
Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness. Cancer research 82 (23) (2022)
Alessia Roma, Matthew Tcheng, Nawaz Ahmed, Sarah Walker, Preethi Jayanth, Mark D Minden, Kristin J Hope, Praveen P N Rao, Jessica Luc, Andrew Charles Doxey, Julie A Reisz, Rachel Culp-Hill, Angelo D'Alessandro, Paul A Spagnuolo
Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid Leukemia. Molecular cancer research : MCR 20 (11) (2022)
Eunice S Wang, Pau Montesinos, Mark D Minden, Je Hwan Lee, Michael Heuser, Tomoki Naoe, Wen-Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K Altman, Violaine Havelange, Anne-Marie Watson, Carlo B Gambacorti-Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E Hill, Stanley C Gill, Elizabeth Shima Rich, Ramon V Tiu
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy. Blood 140 (17) (2022)
Sara Mirali, Aaron Botham, Veronique Voisin, Changjiang Xu, Jonathan R St-Germain, David Sharon, Fieke W Hoff, Yihua Qiu, Rose Hurren, Marcela Gronda, Yulia Jitkova, Boaz Nachmias, Neil MacLean, Xiaoming Wang, Andrea Arruda, Mark D Minden, Terzah M Horton, Steven Mitchell Kornblau, Steven M Chan, Gary D Baider, Brian Raught, Aaron David Schimmer
The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability. Science translational medicine 12 (538) (2021)
Carmelo Gurnari, Simona Pagliuca, Yihong Guan, Vera Adema, Courtney E Hershberger, Ying Ni, Hassan Awada, Sunisa Kongkiatkamon, Misam Zawit, Diego Coutinho, Ilana Renault Zalcberg, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim, Mark D Minden, Joop H Jansen, Manja Meggendorfer, Claudia Haferlach, Babal Kant Jha, Torsten Haferlach, Jaroslaw P Maciejewski, Valeria Visconte
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Blood advances (2021)
Jong Bok Lee, Dilshad H Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Y Konopleva, Michael Andreeff, Mark D Minden, Li Zhang, Aaron David Schimmer
Venetoclax enhances T cell-mediated antileukemic activity by increasing ROS production. Blood 138 (3) (2021)
Sujeetha A Rajakumar, Eniko Papp, Kathy K Lee, Ildiko Grandal, Daniele Merico, Careesa C Liu, Bedilu Allo, Lucia Zhang, Marc D Grynpas, Mark D Minden, Johann K Hitzler, Cynthia J Guidos, Jayne S Danska
B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction. Science translational medicine 12 (561) (2021)
Matthew Tcheng, Mark D Minden, Paul A Spagnuolo
Avocado-derived avocadyne is a potent inhibitor of fatty acid oxidation. Journal of food biochemistry (2021)
Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, Sarah E Church, Stephen Reeder, Heidi Altmann, Amy H Sullivan, Elena J Viboch, Tasleema Patel, Narmin Ibrahimova, Sarah E Warren, Andrea Arruda, Yan Liang, Thomas H Smith, Gemma Ann Foulds, Michael D Bailey, James Gowen-MacDonald, John Muth, Marc Schmitz, Alessandra Cesano, Alan Graham Pockley, Peter J M Valk, Bob Löwenberg, Martin Bornhäuser, Sarah K Tasian, Michael P Rettig, Jan K Davidson-Moncada, John F Dipersio, Sergio Rutella
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia. Science translational medicine 12 (546) (2021)
Stanley Wk Ng, Tracy Murphy, Ian King, Tong Zhang, Michelle Mah, Zhibin Lu, Natalie Stickle, Narmin Ibrahimova, Andrea Arruda, Amanda Mitchell, Ming Mai, Rong He, Bindu Swapna Madala, David S Viswanatha, John E Dick, Steven Mc Chan, Carl Virtanen, Mark D Minden, Timothy R Mercer, Tracy L Stockley, Jean C Y Wang
A Clinical Laboratory-Developed LSC17 Stemness Score Assay for Rapid Risk Assessment of Acute Myeloid Leukemia Patients. Blood advances (2021)
Matthew Tcheng, Alessia Roma, Nawaz Ahmed, Richard W Smith, Preethi Jayanth, Mark D Minden, Aaron D Schimmer, David A Hess, Kristin Hope, Kevin A Rea, Tariq A Akhtar, Eric Bohrnsen, Angelo D'Alessandro, A I-Walid Mohsen, Jerry Vockley, Paul A Spagnuolo
Very long chain fatty acid metabolism is required in acute myeloid leukemia. Blood 137 (25) (2021)
Francesca Lovat, Pierluigi Gasparini, Giovanni Nigita, Karilyn T M Larkin, John C Byrd, Mark D Minden, Michael Andreeff, Bing Z Carter, Carlo M Croce
Loss of expression of both miR-15/16 loci in CML transition to blast crisis. Proceedings of the National Academy of Sciences of the United States of America 118 (11) (2021)
Sagi Abelson, Andy G X Zeng, Ido Nofech-Mozes, Ting Ting Wang, Stanley W K Ng, Mark D Minden, Trevor J Pugh, Philip Awadalla, Liran I Shlush, Tracy Murphy, Steven M Chan, John E Dick, Scott V Bratman
Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing. Science advances 6 (50) (2020)
Fida Khater, Mathieu Lajoie, Sylvie Langlois, Jasmine Healy, Sonia Cellot, Chantal Richer, Patrick Beaulieu, Pascal St-Onge, Virginie Saillour, Mark D Minden, Monia Marzouki, Maja Krajinovic, Henrique Bittencourt, Daniel Sinnett
KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia. Blood 129 (12) (2017)
Alan P Kraguljac, Danielle Croucher, Michael Christian, Narmin Ibrahimova, Vikram Kumar, Gabriella Jacob, Alex Kiss, Mark D Minden, Sangeeta Mehta
Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care Unit. Canadian respiratory journal 2016 (2016)